eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. Please read our Terms of Service before submitting your own eLetter.
Submit a Response to This Article
No eLetters have been published for this article.
Article Tools
- Genetically corrected iPSCs as cell therapy for recessive dystrophic epidermolysis bullosa
iPSCs derived from fibroblasts with mutant type VII collagen were genetically corrected and used as cell therapy in mice with recessive dystrophic epidermolysis bullosa.